Nutrition

The abstract describes improved sleep-disturbance scores and some skills for managing thinking among athletes assigned to finger millet. However, improvement within one group alongside a nonsignificant change in another does not demonstrate a difference between diets. Whether millet improved mental health or cognition more than the usual diet remains uncertain. Other groups' metacognitive changes were nonsignificant.

Keep in mind: The abstract gives no direct between-diet effect estimates or sizes of the score changes. Outcomes came from questionnaires, and all participants were young men, limiting what the study can establish for other groups.

People reporting higher dietary copper intake tended to have slightly higher bone mineral density at the lumbar spine. The hip analysis did not show a statistically clear association. These observational findings cannot show that copper caused the difference, and measuring bone density does not establish that increasing copper intake prevents osteoporosis or fractures.

Keep in mind: The evidence came from observational studies, and the abstract does not report intake thresholds or participant characteristics. Hip results varied substantially across studies.

Limiting the daily eating window without a prescribed calorie limit modestly reduced blood pressure compared with unrestricted eating in adults without diabetes. Several glucose-related measurements also improved. These are changes in measured risk markers; the abstract does not establish fewer cardiovascular events, lasting benefit, or applicability to people with diabetes.

Keep in mind: Trial durations and adverse events are not reported in the abstract. Its conclusion mentions lipid results without estimates, and the summary cannot establish long-term outcomes or show that participants' actual calorie intake stayed unchanged.

Nutritional risk scores identified critically ill patients with higher mortality. Adequate energy intake was associated with lower short-term mortality among high-risk patients in the overall analysis, but that apparent benefit was not established in randomized trials. The score's ability to identify risk does not demonstrate that it can guide calorie support that improves survival.

Keep in mind: The abstract does not define adequate energy intake or describe trial comparator regimens. It also does not explain the design mix behind the overall association, limiting interpretation of why that result differed from the randomized evidence.

The analysis linked a higher dietary n-6 to n-3 fatty acid ratio with a greater likelihood of an ADHD diagnosis after statistical adjustment. It did not test a dietary intervention or establish whether diet preceded ADHD. The findings therefore support an association, while leaving prevention and treatment effects unanswered.

Keep in mind: The abstract does not explain how diet or ADHD diagnosis was measured, or list the adjustment variables. Without a dietary trial or a reported sequence of events, the association cannot establish causation.

Weight, age, dietary inflammatory properties, mental health and diet quality were statistically associated with blood glucose responses after sucrose intake. These are associations within a secondary analysis, so they do not establish that changing any of these factors would improve glucose control. The reported outcomes also do not demonstrate pain relief.

Keep in mind: The analysis was specific to women. Glucose was measured by finger prick without continuous data, and the abstract does not report effect sizes or a sampling schedule. These limits constrain interpretation of the response patterns.

Fasting during pregnancy was associated with slightly lower average birthweight. The pooled low-birthweight analysis did not show a statistically clear association. Because all included studies were observational, these results cannot establish that fasting caused the weight difference or that fasting is safe across pregnancy stages, maternal conditions, or longer-term child outcomes.

Keep in mind: Only a subset of included studies contributed quantitative data, and birthweight estimates varied across studies. The abstract does not describe fasting schedules or reference groups in enough detail to assess comparability.

The pooled trials found that orforglipron reduced body weight and improved blood sugar and lipid measurements compared with placebo in people with obesity. Gastrointestinal side effects and stopping treatment were concerns at some doses. These findings describe weight and laboratory outcomes; they do not establish fewer cardiovascular events or a long-term survival benefit.

Keep in mind: This abstract-based summary lacks treatment durations and detailed results by diabetes status. It also does not report direct dose comparisons that would establish which dose offers the best balance of benefits and harms.

The review reported better muscle strength with probiotics and whole-food diets enriched in fiber, and faster walking with probiotics. Muscle-mass findings depended on diet type and participant subgroup. These signals remain uncertain because most studies had high risk of bias, and studies of people with diagnosed sarcopenia could not contribute to the pooled estimates.

Keep in mind: The abstract omits comparison-group details and confidence intervals for the reported benefits. It also cannot establish whether gut-microbe changes explain the muscle findings.

In this abstract-based review, yerba maté showed possible benefits for selected blood-sugar markers in participants with prediabetes. Across the review, several other metabolic outcomes showed no statistically significant effect, including blood lipids and body-size measures. The abstract does not establish diabetes prevention or weight-loss effectiveness, and the subgroup findings need confirmation.

Keep in mind: The abstract omits treatment duration, comparator details, and units for the reported blood-sugar effects. Adverse events are listed without frequencies or group comparisons, so their relative likelihood cannot be assessed.

Children described as being in need had a higher prevalence of overweight and obesity than the general child population. Regular breakfast, adequate sleep, and physical activity were associated with lower obesity risk. These observational findings identify patterns for further investigation; they do not establish that changing any single behaviour will reduce obesity in this population.

Keep in mind: The abstract does not define 'children in need,' report sample sizes, provide effect estimates, or describe adjustment for confounding. The strength and independence of the associations remain unclear.

In this abstract-based trial, a standardized calorie-restricted meal package plus exercise produced more participants reaching the reported weight-loss thresholds than dietary advice plus exercise. Greater weight loss was also associated with better metabolic and psychological measures. Those associations do not establish that the meal package itself directly caused each of those additional changes.

Keep in mind: The abstract does not provide confidence intervals for the weight-loss threshold comparisons or enough detail about meal content, adherence and participant follow-up to fully assess the reported results.

The review reported reductions in waist circumference with DASH and vegan diets compared with control diets. DASH and ketogenic diets lowered systolic blood pressure versus controls; ketogenic diets also lowered diastolic pressure. The results concern metabolic measurements and do not establish a single best diet for every person with metabolic syndrome.

Keep in mind: The abstract omits units for its numerical mean differences, intervention durations, and details of control diets. This abstract-based summary therefore cannot convey effect sizes reliably or judge long-term clinical benefit.

Across studies of adults, Mediterranean dietary patterns were associated with fewer symptoms of depression and anxiety, less perceived stress, and better quality of life and well-being. These patterns are encouraging, but the review does not show that changing diet caused the differences. Its evidence base was dominated by observational research.

Keep in mind: The abstract gives no outcome-specific effect sizes, follow-up periods or study-quality results. Together with the predominance of observational studies, this limits conclusions about the size, persistence and causality of any benefit.

The review found that tirzepatide probably produces greater weight loss than placebo, with weight differences also present at longer follow-up. That does not establish a broad improvement in health: serious adverse-event evidence was very uncertain, and no clear reduction in major cardiovascular events or deaths was established.

Keep in mind: All included trials involved the drug manufacturer in major roles and were manufacturer-funded. Longer-term findings came from a single study, and uncertainty about withdrawals limits assessment of sustained treatment effects.

Both breakfast-skipping patterns led to lower early-morning artery function measurements than eating breakfast daily in this small crossover trial. Fasting insulin was also higher with both skipping patterns. These are short-term physiological findings in habitual breakfast eaters; the abstract does not establish whether these patterns change the risk of future cardiovascular disease.

Keep in mind: Only 10 healthy young adults completed the short trials. The abstract supplies no effect sizes or confidence intervals for the main comparisons, so the size and precision of the reported differences cannot be assessed here.

Blood HbA1c levels fell from baseline in the morning and dinner groups; body weight and BMI fell in the dinner group. The abstract reports these as within-group changes. Without direct comparisons between groups, the results do not establish that dinner was the best timing or that any schedule outperformed usual eating habits.

Keep in mind: The abstract gives no change magnitudes or between-group effects. Although participants were randomized, the results presented cannot separate a timing effect from other changes associated with eating the test meal.

Across the trials, kefir did not produce statistically significant reductions in systolic or diastolic blood pressure or C-reactive protein compared with no kefir. A subgroup involving longer consumption did show lower CRP, but that finding does not establish a consistent overall effect or show that longer use works better.

Keep in mind: The abstract does not describe the participants' health conditions, kefir amounts, or details of the control conditions. It also gives no effect estimate or confidence interval for the longer-duration subgroup.

The main randomized comparison did not show significantly greater weight loss with the personalized app than with the logging-only app; this does not prove equivalence. Both groups followed a reduced-calorie diet. An adherent subgroup had a more favorable result with the personalized app, but that selected comparison cannot establish that engagement caused better weight loss.

Keep in mind: This abstract-based assessment cannot judge how missing follow-up affected results. The adherence analysis selected people by app usage, so its findings need separate interpretation from the overall randomized comparison.

The review links more frequent eating, especially involving unhealthy foods, along with breakfast skipping and increased snacking, to potentially higher colorectal cancer risk. A shorter gap between the last meal and bedtime was also associated with colorectal cancer risk and deaths related to colorectal cancer. These associations do not establish that changing eating schedules prevents cancer or reduces deaths.

Keep in mind: This abstract-based account has no participant details, follow-up durations, numerical effect estimates, or study-level descriptions. It cannot show the magnitude of associations or how consistently they appeared across studies.

Over the trial, the Mediterranean diet and walking programme did not produce a statistically significant advantage in average quality-of-life utility scores. A separate analysis found fewer participants with declining quality of life. These results suggest a possible difference in maintaining quality of life, while leaving the overall average benefit uncertain.

Keep in mind: The abstract does not report participant numbers or the size of the mean utility-score difference. Follow-up beyond the trial is needed to assess whether the pattern persists.

Breakfast skipping was associated with metabolic syndrome and with abdominal obesity, high blood pressure, elevated blood fats and high blood glucose. The evidence included studies measuring breakfast habits and health at the same time. These associations do not establish that skipping breakfast causes disease or that eating breakfast would prevent it.

Keep in mind: This brief uses only the abstract, which does not describe participants, follow-up periods, breakfast definitions or adjustment for other factors. Those gaps limit interpretation and applicability of the association.

The study found rare genetic variants associated with blood vitamin D levels or deficiency in Qatar Biobank participants. A score built from rare variants also showed statistical associations in a separate replication sample. These results concern genetic patterns and a blood measurement; they do not establish that genetic testing improves symptoms, prevents disease or guides effective supplementation.

Keep in mind: The abstract reports genetic associations and prediction statistics, without testing a treatment strategy. Its focus on a Middle Eastern population also leaves the relevance of these specific findings to other populations uncertain.

Closer Nordic diet adherence was associated with lower mortality in observational cohorts. Separate diet trials reported improvements in blood pressure, fasting glucose, insulin and some lipids. The cohort evidence cannot show that the diet prevents deaths, while the trial changes in health markers do not establish a mortality benefit.

Keep in mind: This abstract-based brief lacks participant details, follow-up periods and certainty ratings. Missing numerical trial estimates limit interpretation of changes in health markers.